Cost Effectiveness of Health Report, May 2022
The May 2022 edition of HFMA’s Cost Effectiveness of Health Report includes a conversation with Lance Robertson, former U.S. Assistant Secretary for Aging at the U.S. Department of Health and Human Services Administration for Community Living, on practical ways the United States can begin to meaningfully address social determinants of health. Another article explores considerations for hospitals and health systems regarding the decision to pursue a “hospital at home” strategy, and a column shares perspectives and lessons learned from a 47-year active member of HFMA on the nation’s evolution toward value.
Road to value begins with addressing social determinants of health
Lance Robertson, a former HHS leader, is encouraged by the federal response to the nation’s need to address problems such as health inequity, increased health risk and avoidable high costs for populations that are adversely affected by social determinants of health (SDoH). He sees addressing SDoH as a necessary preliminary step on the nation’s journey to achieving value in healthcare.
David Johnson: Cracks in the foundation – Overcoming regulatory headwinds
Healthcare leaders have an important opportunity today use the new regulations to drive value-based care throughout their organizations. But that doesn’t mean completely relinquishing their traditional revenue streams. To seize this opportunity, they should undertake a dual transformation that promotes more efficient operation of their traditional businesses, while nurturing and growing new businesses focused on population health and value.
Ken Perez: U.S. demographic realities and the productivity mandate for healthcare
COVID-19’s impact on nursing is undeniable. But focusing too much on the pandemic can obscure longstanding and inexorable demographic trends that are also contributing to growing nursing shortages.
Why real estate should be an integral part of a health system’s resources strategy
The changing healthcare landscape following the pandemic — including, among other factors, the new competitive dynamics as a result of the migration away from inpatient care and the heightened focus on health equity — is making it incumbent on health system leaders to align their real estate resources within their overall approach to strategy, operations and finance.
Steve LeFar talks about the implications of care deferrals due to COVID-19
The economic and social impacts from deferred healthcare due to COVID-19 were already a major concern in the pandemic’s first year, portending severe declines in health status for Americans who stopped seeking care for fear of exposure to the coronavirus. In this Q&A, Strata Decision Technology’s Steve Lefar shares insights based on extensive data that tell the story of deferred care across the nation, and the likelihood that providers will see a rising tide of severely ill patients.
Cost Effectiveness of Health Report, April 2022
The April 2022 edition of HFMA’s Cost Effectiveness of Health Report includes a preview the May issue of hfm, which focuses on telehealth, a key tool for promoting value-based care CEoH. Another article explores ways to promote health equity in revenue cycle processes, and a case study describes how one health system embarked on an initiative to achieve greater diversity among its revenue cycle staff.
Why ensuring the appropriate assignment of observation status patients is so important
Managing observation status requires a focused and consistent effort. Inappropriate assignment of observation status is expensive for patients and hospitals alike and can impede the goal of providing patients with the right care at the right time in the right setting.
Cost Effectiveness of Health Report, March 2022
The March 2022 edition of HFMA’s Cost Effectiveness of Health Report addresses a key prerequisite to achieving cost-effectiveness: engaged caregivers. A preview of the April 2022 hfm cover story details how one health system has responded to its nurses’ need for increased scheduling flexibility, and a commentary explores steps for enabling physicians to play a leadership role in promoting CEoH. Also included is a Q&A exploring activities on the world stage aimed at achieving the United Nation’s sustainable development goals for healthcare and health equity – and how U.S. organizations can play a role.
How U.S. healthcare can play a larger role on the world stage
Judy Kuriansky, PhD, a professor of psychology, NGO representative to United Nations and trustee of the United African Congress, shares her insights and experiences from working to improve healthcare equity and access among populations in the world who are “furthest behind,” which is a priority in the United Nations 2030 Agenda for Sustainable Development. Kuriansky describes recent international efforts aimed at promoting the United Nations 2030 Agenda, and she address ways U.S. health systems could play an important role in such efforts.